Ravi K. Ujjinamatada

An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase/helicase: Synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl)imidazole-1-β-d-ribofuranoside

Ravi K. Ujjinamatada, Andrea Baier, Peter Borowski et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 59 citations · Full text

Hcv Ntpase/helicase, Medicine, Vitro Screening +10

ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity

Tim H. Holmström, Anu‐Maarit Moilanen, Tarja Ikonen et al. · Molecular Cancer Therapeutics · 2018 · 33 citations · Full text

The First Synthesis of a Novel 5:7:5-Fused Diimidazodiazepine Ring System and Some of Its Chemical Properties

Raj Kumar, Ravi K. Ujjinamatada, Ramachandra S. Hosmane · Organic Letters · 2008 · 24 citations · Full text

Synthesis and antimicrobial activity of new benzofuranyl-1,3-benzoxazines and 1,3-benzoxazin-2-ones

Ravi K. Ujjinamatada, Raju S. Appala, Yankanagouda S. Agasimundin · Journal of Heterocyclic Chemistry · 2006 · 23 citations

-Coch2- Bridges, Medicinal Chemistry, Organic Chemistry +6

A novel, broad-spectrum anticancer compound containing the imidazo[4,5-e][1,3]diazepine ring system

Min Xie, Ravi K. Ujjinamatada, Mariola Sadowska et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 19 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Heterocyclic +9